Cargando…

Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results

OBJECTIVES: The fecal immunochemical test (FIT) has low sensitivity for detecting advanced colorectal neoplasia (ACRN); thus, a considerable portion of FIT-negative persons may have ACRN. We aimed to develop a risk-scoring model for predicting ACRN in FIT-negative persons. MATERIALS AND METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Yoon Suk, Park, Chan Hyuk, Kim, Nam Hee, Park, Jung Ho, Park, Dong Il, Sohn, Chong Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764375/ https://www.ncbi.nlm.nih.gov/pubmed/29324874 http://dx.doi.org/10.1371/journal.pone.0191125

Ejemplares similares

Impact of temperature and humidity on performance of the fecal immunochemical test for advanced colorectal neoplasia
por: Park, Chan Hyuk, et al.
Publicado: (2019)

A Combination of Fecal Immunochemical Test Results and Iron Deficiency Anemia for Detection of Advanced Colorectal Neoplasia in Asymptomatic Men
por: Kim, Nam Hee, et al.
Publicado: (2017)

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
por: Kim, Nam Hee, et al.
Publicado: (2017)

Correlation between Hepatitis B Virus Infection and Colorectal Neoplasia
por: Jung, Yoon Suk, et al.
Publicado: (2019)

Impact of nonalcoholic fatty liver disease on the risk of metachronous colorectal neoplasia after polypectomy
por: Kim, Nam Hee, et al.
Publicado: (2021)

Changes in Abdominal Obesity Affect the Risk of Metachronous Advanced Colorectal Neoplasia Development after Polypectomy
por: Jung, Yoon Suk, et al.
Publicado: (2020)

Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
por: Kim, Nam Hee, et al.
Publicado: (2017)

Coexistent adenoma and serrated polyps on index colonoscopy and the risk of metachronous advanced colorectal neoplasia
por: Park, Soo-Kyung, et al.
Publicado: (2019)

Age at menarche and risk of colorectal adenoma
por: Kim, Nam Hee, et al.
Publicado: (2019)

Positive fecal immunochemical test results are associated with non-colorectal cancer mortality
por: Jung, Yoon Suk, et al.
Publicado: (2022)

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
por: Iovanescu, Dana, et al.
Publicado: (2016)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
por: Liu, Feiyuan, et al.
Publicado: (2021)

Comparison of colonoscopy after colonic diverticulitis and positive fecal immunochemical tests for the detection of colorectal neoplasia
por: Nakamatsu, Dai, et al.
Publicado: (2021)

Performance of the fecal immunochemical test for colorectal cancer and advanced neoplasia in individuals under age 50
por: Heer, Emily, et al.
Publicado: (2023)

Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test
por: Li, Wen, et al.
Publicado: (2018)

Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
por: Kim, Dae Ho, et al.
Publicado: (2018)

Comparison of Risk of Metachronous Advanced Colorectal Neoplasia in Patients with Sporadic Adenomas Aged < 50 Versus ≥ 50 years: A Systematic Review and Meta-Analysis
por: Jung, Yoon Suk, et al.
Publicado: (2021)

Risk Scoring Systems for Predicting the Presence of Colorectal Neoplasia by Fecal Immunochemical Test Results in Chinese Population
por: Wu, Weimiao, et al.
Publicado: (2022)

Interval Cancer Rate and Diagnostic Performance of Fecal Immunochemical Test According to Family History of Colorectal Cancer
por: Jung, Yoon Suk, et al.
Publicado: (2020)

Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies
por: Kim, Nam Hee, et al.
Publicado: (2017)

Appropriate Surveillance Interval after Colonoscopic Polypectomy in Patients Younger than 50 Years
por: Jung, Yoon Suk, et al.
Publicado: (2019)

Is Colonoscopic Screening Necessary for Patients Younger than 50 Years with Gastric Adenoma or Cancer?
por: Kim, Nam Hee, et al.
Publicado: (2017)

Comment on “ Positive fecal immunochemical test results are associated with non-colorectal cancer mortality”
por: Park, Yong Eun
Publicado: (2023)

Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study
por: Liles, Elizabeth G., et al.
Publicado: (2018)

Risk of colorectal cancer in patients with positive results of fecal immunochemical test performed within 5 years since the last colonoscopy
por: Jung, Yoon Suk, et al.
Publicado: (2021)

Metabolic syndrome is a risk factor for adenoma occurrence at surveillance colonoscopy: A single-center experience in Korea
por: Kim, Nam Hee, et al.
Publicado: (2016)

Should asymptomatic young men with iron deficiency anemia necessarily undergo endoscopy?
por: Kim, Nam Hee, et al.
Publicado: (2018)

Comparison of One versus Two Fecal Immunochemical Tests in the Detection of Colorectal Neoplasia in a Population-Based Colorectal Cancer Screening Program
por: Moosavi, Sarvenaz, et al.
Publicado: (2016)

Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case–Control Study
por: Kim, Su Young, et al.
Publicado: (2021)

The relationship between diverticulosis and colorectal neoplasia: A meta-analysis
por: Lee, Hyun Jung, et al.
Publicado: (2019)

Metabolically Healthy Obesity Is Associated with an Increased Risk of Colorectal Adenoma Occurrence Diagnosed by Surveillance Colonoscopy
por: Chae, Hyunbeom, et al.
Publicado: (2021)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia
por: Symonds, Erin L, et al.
Publicado: (2016)

Positive Fecal Immunochemical Test Results Are Associated with Increased Risks of Esophageal, Stomach, and Small Intestine Cancers
por: Jung, Yoon Suk, et al.
Publicado: (2020)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
por: Wong, Sunny H, et al.
Publicado: (2017)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Efficacy and Tolerability of 14-Day Tegoprazan- versus Rabeprazole-Based Triple Therapy for Eradication of Helicobacter pylori: A Real-World Evidence Study
por: Jung, Yoon Suk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7h9jjmkmdgj31r88uq7ej7q4oq